Form 4 for CYRX Cryoport, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-14 · accession 0001104659-26-029718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-14 | CYRX | Sawicki Mark W | CSO | A - Grant | $0.00 | +22.8K | 106.9K | +27% | $0 |
| D | 2026-03-17 | 2026-03-16 | CYRX | Sawicki Mark W | CSO | S - Sale | $8.00 | -3,235 | 103.7K | -3% | -$25.9K |
| D | 2026-03-17 | 2026-03-14 | CYRX | Sawicki Mark W | CSO | A - Grant | $0.00 | +68.5K | 68.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-14 | A | A | 22,845 | $0.00 | 106,932 | D | — | — | (F1) Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027. |
| 2 | Common | Common Stock | 2026-03-16 | S | D | 3,235 | $8.00 | 103,697 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-03-14 | A | A | 68,534 | $0.00 | 68,534 | D | $8.60 · — to 2033-03-14 | 68,534 Common Stock | (F3) 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026. |